136 cr doses of Covishield, Covaxin to lead India’s COVID-19 vaccination programme between Aug-Dec, Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com

For the next four months, India’s vaccine programme will be accelerated by the Serum Institute of India’s (SII) Covishield and Bharat Biotech’s Covaxin., For the next four months, India’s vaccine programme will be accelerated by the Serum Institute of India’s (SII) Covishield and Bharat Biotech’s Covaxin., , Read More